Danazol in Hemophilia

W K Krick

doi:10.1056/nejm198407053110115

Danazol in Hemophilia

W K Krick

In: New England Journal of Medicine · 1984 · vol. 311(1) , pp. 54–55 · doi:10.1056/nejm198407053110115 · PMID:6727968 · W4300469865

article OA: closed CC0 ⤵ 2 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This paper examines the use of danazol in treating hemophilia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Danazol 1982

Cited by (2)

References (5)

Danazol via openalex
doi:10.1056/nejm198306093082305 via openalex
doi:10.1016/0049-3848(81)90052-9 via openalex
doi:10.1056/nejm198306093082306 via openalex
doi:10.1111/j.1365-2141.1972.tb05701.x via openalex

Cited by (2)

Source provenance

openalex: last seen: 2026-05-10T11:03:44.321222+00:00

License: CC0 · commercial use OK

[1] Danazol 1982